SCHEMBL8003302

SCHEMBL8003302

COCC(C)(C)C/C=C/c1cc(C)ccc1OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.40
ALDH1A1 P00352 4/20 0.37
CYP3A4 P08684 1/20 0.37
MAPT P10636 3/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
LMNA P02545 2/20 0.36
CYP1A1 P04798 3/20 0.36
CYP1B1 Q16678 3/20 0.36
CYP1A2 P05177 1/20 0.36
NFE2L2 Q16236 1/20 0.36
L3MBTL4 Q8NA19 1/20 0.35
L3MBTL3 Q96JM7 1/20 0.35
BACE1 P56817 1/20 0.35
KDM4E B2RXH2 2/20 0.34
HPGD P15428 3/20 0.33
USP2 O75604 2/20 0.33
MAPK1 P28482 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
JUN P05412 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7989707 0.86 ACHE (0.38) ACHEALDH1A1CYP3A4MAPTKMT2A
SCHEMBL13822036 0.84 CYP1A1 (0.35) ALDH1A1MAPTKMT2AMEN1CYP1A1
SCHEMBL13845927 0.84 CYP1A1 (0.35) ALDH1A1MAPTCYP1A1CYP1B1CYP1A2
SCHEMBL7999209 0.84 PDE5A (0.39) ACHEALDH1A1CYP3A4MAPTKMT2A
SCHEMBL7990252 0.79 ACHE (0.42) ACHEALDH1A1CYP3A4MAPTKMT2A
SCHEMBL8000126 0.76 ACHE (0.44) ACHEALDH1A1CYP3A4MAPTKMT2A
SCHEMBL8002469 0.74 ACHE (0.40) ACHEALDH1A1CYP3A4MAPTKMT2A
SCHEMBL7990557 0.74 ACHE (0.40) ACHEALDH1A1CYP3A4MAPTKMT2A
SCHEMBL7990406 0.74 ACHE (0.40) ACHEALDH1A1CYP3A4MAPTKMT2A
SCHEMBL7990256 0.74 ACHE (0.42) ACHEALDH1A1CYP3A4MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009117594-A1 FLUORINATED MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-09-24 WO disclosed